Edition:
India

Amphastar Pharmaceuticals Inc (AMPH.OQ)

AMPH.OQ on NASDAQ Stock Exchange Global Select Market

19.37USD
2:29am IST
Change (% chg)

$-0.09 (-0.46%)
Prev Close
$19.46
Open
$19.41
Day's High
$19.45
Day's Low
$19.20
Volume
51,476
Avg. Vol
89,876
52-wk High
$19.94
52-wk Low
$12.06

Latest Key Developments (Source: Significant Developments)

Amphastar Announces Approval For Sodium Nitroprusside Injection, USP
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Amphastar Pharmaceuticals Inc ::AMPHASTAR ANNOUNCES APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION, USP.AMPHASTAR PHARM - ANTICIPATES LAUNCHING SODIUM NITROPRUSSIDE INJECTION, USP IN Q1 OF 2018.AMPHASTAR PHARMACEUTICALS - FDA GRANTED APPROVAL OF ABBREVIATED NEW DRUG APPLICATION FOR SODIUM NITROPRUSSIDE INJECTION 25MG/ML, 2ML SINGLE DOSE VIAL.  Full Article

Amphastar Announces Approval For Medroxyprogesterone Acetate Injectable Suspension, USP
Thursday, 30 Nov 2017 

Nov 29 (Reuters) - Amphastar Pharmaceuticals Inc ::AMPHASTAR ANNOUNCES APPROVAL FOR MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION, USP.SAYS AMPHASTAR ANTICIPATES LAUNCHING ITS PRODUCT IN Q1 OF 2018.SAYS U.S. FDA GRANTED APPROVAL OF 2 ABBREVIATED NEW DRUG APPLICATIONS FOR MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION.SAYS APPROVAL FOR MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION, USP 150 MG/ML, 1ML VIAL, & 1ML PREFILLED SYRINGE, RESPECTIVELY.  Full Article

Amphastar Pharma reports results for three months ended Sept
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Amphastar Pharmaceuticals Inc :Amphastar Pharmaceuticals reports financial results for the three months ended September 30, 2017.Q3 GAAP earnings per share $0.00.Q3 revenue $57.9 million versus i/b/e/s view $57.2 million.Q3 adjusted non-GAAP earnings per share $0.07.Q3 earnings per share view $0.02 -- Thomson Reuters I/B/E/S.  Full Article

Amphastar Pharma Q2 adjusted non-gaap earnings per share $0.23
Tuesday, 9 Aug 2016 

Amphastar Pharmaceuticals Inc : Q2 gaap earnings per share $0.15 . Q2 earnings per share view $0.01 -- Thomson Reuters I/B/E/S . Amphastar pharmaceuticals reports financial results for the three months ended june 30, 2016 . Q2 revenue $68 million versus i/b/e/s view $62.1 million .Q2 adjusted non-gaap earnings per share $0.23.  Full Article

Amphastar buys International Medication Systems(UK)for $7.7 mln
Thursday, 4 Aug 2016 

Amphastar Pharmaceuticals Inc : Purchases International Medication Systems (UK) Limited from UCB Pharma GMBH .Deal for $7.7 million.  Full Article

Amphastar Pharmaceuticals Q1 EPS $0.05
Tuesday, 10 May 2016 

Amphastar Pharmaceuticals Inc : Amphastar pharmaceuticals reports financial results for the first quarter ended march 31, 2016 . Q1 earnings per share $0.05 . Q1 revenue $59.4 million versus i/b/e/s view $62 million . Q1 earnings per share view $-0.03 -- Thomson Reuters I/B/E/S .Q1 adjusted non-gaap earnings per share $0.12.  Full Article